about ers
ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use. LEARN MORE
CRISPR-Cas9 TECHNOLOGY
“CRISPR” refers to clustered regularly interspaced short palindromic repeats. The CRISPR platform technology utilizes a molecular complex comprised of the protein Cas9 together with one or more guide RNAs which binds to the genome in living cells at any desired locations. LEARN MORE
